SCHEMBL29706587

SCHEMBL29706587

COc1c(-c2ccc3c(c2)OCO3)oc2cc(OCC=C(C)C)cc(OC)c2c1=O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 5/20 0.53
▸ ABCG2 Q9UNQ0 5/20 0.53
▸ ALDH1A1 P00352 4/20 0.53
▸ ABCB1 P08183 4/20 0.53
▸ ABCC1 P33527 3/20 0.53
▸ KDM4E B2RXH2 2/20 0.53
▸ MEN1 O00255 2/20 0.53
▸ MAPK1 P28482 2/20 0.53
▸ KMT2A Q03164 2/20 0.53
▸ TDP1 Q9NUW8 1/20 0.53
▸ MAPT P10636 2/20 0.53
▸ SMN1; SMN2 Q16637 2/20 0.53
▸ HSD17B10 Q99714 2/20 0.53
▸ LMNA P02545 1/20 0.53
▸ TP53 P04637 1/20 0.53
▸ HPGD P15428 1/20 0.53
▸ ADORA3 P0DMS8 4/20 0.53
▸ SLC22A2 O15244 1/20 0.53
▸ SLC22A1 O15245 1/20 0.53
▸ CYP1A2 P05177 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27084612 0.81 ABCB1 (0.51) CYP3A4ABCG2ALDH1A1ABCB1KDM4E
SCHEMBL3173862 0.79 ABCG2 (0.62) CYP3A4ABCG2ALDH1A1ABCB1ABCC1
SCHEMBL9063296 0.77 CYP3A4 (0.60) CYP3A4ABCG2ALDH1A1ABCB1ABCC1
SCHEMBL9063795 0.77 ABCB1 (0.70) CYP3A4ABCG2ALDH1A1ABCB1KDM4E
SCHEMBL3181749 0.76 ADORA3 (0.51) CYP3A4ABCG2ALDH1A1ABCB1ABCC1
SCHEMBL9063848 0.73 CYP1A1 (0.58) CYP3A4ABCG2ALDH1A1ABCB1KDM4E
Meliternatin SCHEMBL9063713 0.73 CYP1A2 (0.55) CYP3A4ABCG2ALDH1A1ABCB1ABCC1
SCHEMBL30669273 0.73 CYP1A1 (0.58) CYP3A4ABCG2ALDH1A1ABCB1KDM4E
Demethoxykanugin SCHEMBL13582763 0.71 CYP3A4 (0.78) CYP3A4ABCG2ALDH1A1ABCB1KDM4E
Pentamethylquercetin SCHEMBL2286327 0.71 ABCG2 (1.00) CYP3A4ABCG2ALDH1A1ABCB1ABCC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260021998-A1 AUTONOMOUS INDUSTRIAL TRUCK METRALABS GMBH NEUE TECHNOLOGIEN UND SYSTEME (DE) 2026-01-22 — — US disclosed
US-12371499-B2 Method of treating cancer using anti-AV8 antibodies THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2025-07-29 — — US disclosed
US-12365570-B2 Autonomous industrial truck METRALABS GMBH NEUE TECHNOLOGIEN UND SYSTEME (DE) 2025-07-22 — — US disclosed
US-20240067510-A1 Autonomous Industrial Truck METRALABS GMBH NEUE TECHNOLOGIEN UND SYSTEME (DE) 2024-02-29 — — US disclosed
EP-4249421-A2 AUTONOMOUS INDUSTRIAL TRUCK MetraLabs GmbH Neue Technologien und Systeme (DE) 2023-09-27 — — EP disclosed
EP-4239430-A1 AUTONOMOUS INDUSTRIAL TRUCK MetraLabs GmbH Neue Technologien und Systeme (DE) 2023-09-06 — — EP disclosed
EP-3887917-B1 AUTONOMOUS INDUSTRIAL TRUCK METRALABS GMBH NEUE TECH UND SYSTEME (DE) 2023-06-07 — — EP disclosed
US-20220289850-A1 ANTI-AVBETA8 ANTIBODIES AND COMPOSITIONS AND USES THEREOF PFIZER INC. (US) 2022-09-15 — — US disclosed
CN-114930263-A Autonomous transport vehicle 梅特拉莱布斯新技术和系统公司 2022-08-19 — — CN disclosed
US-11359024-B2 Anti-AVB8 antibodies and compositions and uses thereof PFIZER INC. (US) 2022-06-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260021998-A1 AUTONOMOUS INDUSTRIAL TRUCK AGL, IGLV6-57, INTS9 CYP3A4 3627/4885ABCG2 2137/4885ALDH1A1 3330/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback